The estimated Net Worth of Douglas G Watson is at least $1.07 Milion dollars as of 6 January 2015. Douglas Watson owns over 30,000 units of Orasure Technologies stock worth over $739,581 and over the last 21 years Douglas sold OSUR stock worth over $334,800.
Douglas has made over 5 trades of the Orasure Technologies stock since 2011, according to the Form 4 filled with the SEC. Most recently Douglas exercised 30,000 units of OSUR stock worth $168,000 on 6 January 2015.
The largest trade Douglas's ever made was exercising 60,000 units of Orasure Technologies stock on 20 November 2012 worth over $418,200. On average, Douglas trades about 8,148 units every 43 days since 2004. As of 6 January 2015 Douglas still owns at least 174,019 units of Orasure Technologies stock.
You can see the complete history of Douglas Watson stock trades at the bottom of the page.
Douglas's mailing address filed with the SEC is 52 LIBERTY CORNER ROAD, , FAR HILLS, NJ, 07931.
Over the last 21 years, insiders at Orasure Technologies have traded over $21,897,384 worth of Orasure Technologies stock and bought 196,200 units worth $1,037,188 . The most active insiders traders include Douglas A Michels, Ronald H Spair a Michael J Gausling. On average, Orasure Technologies executives and independent directors trade stock every 43 days with the average trade being worth of $221,123. The most recent stock trade was executed by Kathleen Gallagher Weber on 19 December 2023, trading 24,129 units of OSUR stock currently worth $194,238.
based in bethlehem, pennsylvania, orasure technologies is a leader in the development, manufacture and distribution of oral fluid diagnostic and collection devices and other technologies designed to detect or diagnose critical medical conditions. these products include tests for the detection of antibodies to the hiv virus, including the oraquick® in-home hiv test, oraquick advance® rapid hiv-1/2 antibody test and the orasure® hiv-1 oral specimen collection device, a test for antibodies to the hcv virus, the oraquick® hcv rapid antibody test, and oral fluid testing solutions for drugs of abuse testing, including intercept® oral fluid drug testing system and q.e.d.® saliva alcohol test. orasure also manufactures and sells several leading cryosurgical products. these include: histofreezer®, a product for the cryosurgical removal of common and plantar warts and several other benign skin lesions, sold to the professional or physician office market, as well as an over-the-counter product fo
Orasure Technologies executives and other stock owners filed with the SEC include: